Erin Garner, DO
Obstetrics & Gynecology · Abilene, TXNPI 1275863029
Payments from drug & device makers
What this record shows
This record is dominated by education: $40,085 of the $51,561 with a category attached, or 77.7%. Intuitive Surgical accounts for 96.5% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2022 at $22,258 and has fallen 98.8% since, to $266 in 2025. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $316.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$50K
- AbbVie$517
- Amgen$305
- Astellas Pharma US Inc$220
- Sumitomo Pharma America, Inc.$160
- Mayne Pharma Commercial LLC$88
- plus $498 from 16 others
What the payments were for
- Consulting fees$250%
- Travel & lodging$6,89813%
- Food & beverage$4,5539%
- Education$40,08578%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 66 | $49,774 |
| AbbVie | 39 | $517 |
| Amgen | 14 | $305 |
| Astellas Pharma US Inc | 7 | $220 |
| Sumitomo Pharma America, Inc. | 6 | $160 |
| Mayne Pharma Commercial LLC | 4 | $88 |
| Biogen | 4 | $87 |
| Evofem Biosciences, Inc. | 4 | $65 |
| Pfizer | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $38 |
| Exeltis, USA Inc. | 2 | $36 |
| Shield Therapeutics Inc | 1 | $34 |
| Novo Nordisk | 2 | $29 |
| Bayer | 1 | $27 |
| Coopersurgical, Inc. | 1 | $25 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Exact Sciences | 1 | $15 |
| Merck | 1 | $15 |
| Minerva Surgical, Inc | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$49,215
How this compares
$51,561 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProliaDenosumab | 24 | $41,131 |
| PremarinEstrogens, Conjugated | 14 | $7,406 |
| VeozahFezolinetant | 13 | $6,548 |
| MyrbetriqMirabegron | 11 | $6,372 |
| Estradiol | 130 | $5,942 |
| Raloxifene Hcl | 25 | $1,795 |
| Solifenacin Succinate | 47 | $1,677 |
| Clobetasol Propionate | 21 | $627 |
| Medroxyprogesterone Acetate | 32 | $482 |
| Levothyroxine Sodium | 29 | $466 |
| Alendronate Sodium | 18 | $414 |
| Ibandronate Sodium | 13 | $386 |
| Oxybutynin Chloride ErOxybutynin Chloride | 11 | $277 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $273 |
| Bupropion XlBupropion Hcl | 13 | $226 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenProlia | $305 | $41,13124 claims |
| Astellas Pharma US IncVeozah, Myrbetriq | $220 | $12,92024 claims |
| PfizerPremarin | $52 | $7,40614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Other obstetrics & gynecology in Abilene
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.